欢迎来到天天文库
浏览记录
ID:54982287
大小:252.02 KB
页数:3页
时间:2020-05-07
《加味左金丸治疗肝胃不和型反流性食管炎临床观察-论文.pdf》由会员上传分享,免费在线阅读,更多相关内容在应用文档-天天文库。
1、2014年6月第21卷第6期中国中医药信息杂志·35·加味左金丸治疗肝胃不和型反流性食管炎临床观察李奕升,郭洪波,罗辉娥,马厚蓉深圳市龙岗区人民医院中心城社区健康服务中心,广东深圳518172摘要:目的观察加味左金丸联合西药治疗肝胃不和型反流性食管炎的临床疗效。方法将90例患者随机分为观察组和对照组,每组45例。对照组予雷贝拉唑钠肠溶胶囊和多潘立酮片,观察组在对照组治疗基础上给予加味左金丸治疗,连用4周。观察2组患者的临床疗效、治疗前后的中医证候积分及胃镜改善效果。结果,临床疗效比较,观察组总有效率为95.5%(43/45),对照组为93.3%(42/45),差
2、异无统计学意义(尸>0.05):观察组显效率为77.8%(35/45),对照组为57.8%(26/45),差异有统计学意义(P3、识码:A文章编号:1005—5304(2014)06—0035—03EffectofJiaweiZuojinPillsonRefluxEsophagitiswithLiver-StomachDisharmonySyndromeL1Yi—sheng,GUOHong—bo,LUOHui—e,MAHou-rong(CentralCityCommunityHealthServiceCenter,LongganDistrictPeopleHospitalofShenzhen,Shenzhen518172,China)Abstract:0bjeetiveToobservet4、heclinicaleffectofJiaweiZuojinPillscombinedwithwesternmedicineonrefluxesophagitiswithliver—stomachdisharmonysyndrome.MethodsTotally90casesweredi~dedintoobservationgroup(45cases)andcontrolgroup(45cases).Thecontrolgroupwasgivenrabeprazolesodiumenteric—coatedcapsuleanddomperidonetablets5、,andtheobservationgroupwasgivenJiaweiZuojinPi1lsadditionallyforfourweeks.Theclinicaleffect.TCMsyndromescoreandendoscopicimprovementwereobserved.ResultsThetotaleffectiverateofobservationgroupwas95.5%(43/45),controlgroupwas93.3%(42/45),withnosignificantdifferencebetweenthetwogroups(P>O6、.05).Theexcellentrateofobservationgroupwas77.8%(35/45);controlgroupwas57.8%(26/45),withsignificantdifference(P<0.05).TCMsyndromescorewasimprovedinbothgroups(P7、icofobservationgroupandcontrolgroupwas96.5%(43/45)and77.8%(35/45)respectively,withsignificantdifference(P8、agitis:liver
3、识码:A文章编号:1005—5304(2014)06—0035—03EffectofJiaweiZuojinPillsonRefluxEsophagitiswithLiver-StomachDisharmonySyndromeL1Yi—sheng,GUOHong—bo,LUOHui—e,MAHou-rong(CentralCityCommunityHealthServiceCenter,LongganDistrictPeopleHospitalofShenzhen,Shenzhen518172,China)Abstract:0bjeetiveToobservet
4、heclinicaleffectofJiaweiZuojinPillscombinedwithwesternmedicineonrefluxesophagitiswithliver—stomachdisharmonysyndrome.MethodsTotally90casesweredi~dedintoobservationgroup(45cases)andcontrolgroup(45cases).Thecontrolgroupwasgivenrabeprazolesodiumenteric—coatedcapsuleanddomperidonetablets
5、,andtheobservationgroupwasgivenJiaweiZuojinPi1lsadditionallyforfourweeks.Theclinicaleffect.TCMsyndromescoreandendoscopicimprovementwereobserved.ResultsThetotaleffectiverateofobservationgroupwas95.5%(43/45),controlgroupwas93.3%(42/45),withnosignificantdifferencebetweenthetwogroups(P>O
6、.05).Theexcellentrateofobservationgroupwas77.8%(35/45);controlgroupwas57.8%(26/45),withsignificantdifference(P<0.05).TCMsyndromescorewasimprovedinbothgroups(P7、icofobservationgroupandcontrolgroupwas96.5%(43/45)and77.8%(35/45)respectively,withsignificantdifference(P8、agitis:liver
7、icofobservationgroupandcontrolgroupwas96.5%(43/45)and77.8%(35/45)respectively,withsignificantdifference(P8、agitis:liver
8、agitis:liver
此文档下载收益归作者所有